High Output Heart Failure Secondary Due to Large Arteriovenous Fistula
Background: Arteriovenous fistula (AVF) creation is a commonly performed procedure for patients who suffered from end-stage renal disease (ESRD) and require a permanent vascular access in order to receive long-term haemodialysis. However, these AVF may have a significant deleterious effect on cardiac hemodynamic functions due to increasing cardiac output (CO) and can lead into high output heart failure.
Case Illustration: Female, 36 years old complained dyspnoea on effort, ascites and lower extremity oedema since 6 months ago. She had history of chronic kidney disease and routinely undergoing haemodialysis with brachiocephalic AVF that enlarged since 2 years ago. Physical examination revealed increased jugular vein pressure, hepatomegaly, ascites and giant draining vein of left brachiocephalic AVF with positive Nicoladoni-Branham sign. Echocardiography examination showed dilated right atrium and right ventricle, left ventricle diastolic D-shaped, normal left ventricular ejection fraction with increase right ventricle CO and cardiac index (CI) 7,8 L/minutes/m2, moderate pulmonary regurgitation, severe tricuspid regurgitation (TR) and high probability of pulmonary hypertension. Vascular ultrasound revealed enlarged draining vein with high AVF blood flow rate. Patient then referred to vascular surgeon and decided to undergo ligation of AVF draining vein. After ligation, patient’s right heart failure symptoms were improved and had a better quality of life. upon echocardiography control examination revealed significant improvement of left ventricle diastolic D-shaped.
Conclusion: High output heart failure is one of a potential serious complication upon creating AVF haemodialysis vascular access. Routine screening of AVF blood flow rate, identifying high risk patients, and early management is very important to prevent irreversible myocardial damage.
Copyright (c) 2025 Willis Kwandou, Harry Pribadi, Agnes Lucia Panda

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Cardiovascular and Cardiometabolic Journal (CCJ) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
-
Authors who publish with Cardiovascular and Cardiometabolic Journal (CCJ) agree to the following terms:
-
The journal allows the author to hold the copyright of the article without restrictions.
-
The journal allows the author(s) to retain publishing rights without restrictions.
-
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA).